VF
IOBT

Virtu Financial’s IO Biotech IOBT Stock Holding History

Virtu Financial’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,078
Closed -$12K – 1963
2025
Q4 		$12K Sell
19,078
-19,985
-51% -$14.9K ﹤0.01% 1494
2025
Q3 		$14K Buy
+39,063
New +$67.3K ﹤0.01% 1313
2024
Q4 		– Sell
-17,954
Closed -$19K – 1779
2024
Q3 		$19K Buy
+17,954
New +$22.6K ﹤0.01% 1134
2022
Q1 		– Sell
-12,665
Closed -$83K – 1740
2021
Q4 		$83K Buy
+12,665
New +$122K 0.01% 1204

Other funds holding IOBT

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return

Virtu Financial's IOBT Position: Q1 2026 in Review

Virtu Financial sold out of IO Biotech (IOBT) in Q1 2026, closing a stake of 19,078 shares — an estimated $12K sold.

Virtu Financial first reported a position in IOBT in Q4 2021 and held it in 4 quarters. The position peaked at $83K in Q4 2021. 12 funds tracked by Wall St. Rank hold IOBT as of Q1 2026.

  • Virtu Financial reported no remaining IO Biotech position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 19,078 IO Biotech shares in Q1 2026, an estimated $12K.
  • Virtu Financial first reported a position in IO Biotech in Q4 2021 and held it in 4 quarters.
  • Virtu Financial's IO Biotech position peaked at $83K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held IO Biotech as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.